IL152474A0 - Antihypertensive agents and use - Google Patents

Antihypertensive agents and use

Info

Publication number
IL152474A0
IL152474A0 IL15247401A IL15247401A IL152474A0 IL 152474 A0 IL152474 A0 IL 152474A0 IL 15247401 A IL15247401 A IL 15247401A IL 15247401 A IL15247401 A IL 15247401A IL 152474 A0 IL152474 A0 IL 152474A0
Authority
IL
Israel
Prior art keywords
antihypertensive agents
antihypertensive
agents
Prior art date
Application number
IL15247401A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL152474A0 publication Critical patent/IL152474A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15247401A 2000-04-26 2001-03-22 Antihypertensive agents and use IL152474A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19985500P 2000-04-26 2000-04-26
US24228000P 2000-10-20 2000-10-20
PCT/US2001/009088 WO2001080847A2 (en) 2000-04-26 2001-03-22 Combination of carboxyalkylethers with antihypertensives and pharmaceutical use

Publications (1)

Publication Number Publication Date
IL152474A0 true IL152474A0 (en) 2003-05-29

Family

ID=26895229

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15247401A IL152474A0 (en) 2000-04-26 2001-03-22 Antihypertensive agents and use

Country Status (34)

Country Link
EP (1) EP1280522B1 (cs)
JP (1) JP2003531170A (cs)
KR (1) KR20020091245A (cs)
CN (1) CN1426299A (cs)
AP (1) AP2002002665A0 (cs)
AR (1) AR031104A1 (cs)
AT (1) ATE283691T1 (cs)
AU (1) AU2001247658A1 (cs)
BG (1) BG107264A (cs)
BR (1) BR0110234A (cs)
CA (1) CA2405559A1 (cs)
CZ (1) CZ20023459A3 (cs)
DE (1) DE60107559T2 (cs)
DO (1) DOP2001000150A (cs)
EA (1) EA005245B1 (cs)
EE (1) EE200200611A (cs)
ES (1) ES2231470T3 (cs)
HR (1) HRP20020936A2 (cs)
HU (1) HUP0300403A3 (cs)
IL (1) IL152474A0 (cs)
IS (1) IS6570A (cs)
MA (1) MA26894A1 (cs)
MX (1) MXPA02009662A (cs)
NO (1) NO20025135L (cs)
NZ (1) NZ521713A (cs)
OA (1) OA12252A (cs)
PA (1) PA8516001A1 (cs)
PE (1) PE20011308A1 (cs)
PL (1) PL357906A1 (cs)
PT (1) PT1280522E (cs)
SK (1) SK15132002A3 (cs)
SV (1) SV2002000367A (cs)
TN (1) TNSN01061A1 (cs)
WO (1) WO2001080847A2 (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (en) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC New cholesterolemia-lowering carboxyalkylether compound
BRPI0812597A2 (pt) * 2007-06-21 2015-02-18 Actimis Pharmaceuticals Inc Sal, composição farmacêutica, métodos para o tratamento, prevenção ou melhora de um ou mais sintomas de uma doença mediada por crth2, de uma doença relacionada com eosinófilo, de uma doença relacionada com basófilo, e de uma doença inflamatória, e, processo para a preparação do sal
DE102008026033B4 (de) * 2008-05-30 2017-08-24 Voith Patent Gmbh Antriebsstrang mit einer hydrodynamischen Maschine
SI23149A (sl) * 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) * 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
HUP0300403A2 (hu) 2003-06-28
AR031104A1 (es) 2003-09-10
SK15132002A3 (sk) 2003-08-05
AU2001247658A1 (en) 2001-11-07
EA200200953A1 (ru) 2003-04-24
WO2001080847A3 (en) 2002-07-18
OA12252A (en) 2006-05-11
IS6570A (is) 2002-09-27
HRP20020936A2 (en) 2004-12-31
ATE283691T1 (de) 2004-12-15
EP1280522B1 (en) 2004-12-01
PL357906A1 (en) 2004-08-09
NZ521713A (en) 2004-09-24
CA2405559A1 (en) 2001-11-01
BR0110234A (pt) 2003-03-05
CZ20023459A3 (cs) 2003-05-14
CN1426299A (zh) 2003-06-25
ES2231470T3 (es) 2005-05-16
BG107264A (en) 2003-07-31
NO20025135D0 (no) 2002-10-25
MA26894A1 (fr) 2004-12-20
PA8516001A1 (es) 2002-09-17
DE60107559D1 (de) 2005-01-05
NO20025135L (no) 2002-11-27
MXPA02009662A (es) 2003-03-10
EE200200611A (et) 2004-06-15
PT1280522E (pt) 2005-02-28
TNSN01061A1 (en) 2005-11-10
SV2002000367A (es) 2002-08-26
EA005245B1 (ru) 2004-12-30
HUP0300403A3 (en) 2005-03-29
JP2003531170A (ja) 2003-10-21
EP1280522A2 (en) 2003-02-05
DE60107559T2 (de) 2005-04-14
KR20020091245A (ko) 2002-12-05
DOP2001000150A (es) 2002-08-15
AP2002002665A0 (en) 2002-12-31
WO2001080847A2 (en) 2001-11-01
PE20011308A1 (es) 2002-01-18

Similar Documents

Publication Publication Date Title
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
AU9667901A (en) Mycoattractants and mycopesticides
PL366038A1 (en) Nucleoside compounds and uses thereof
IL141034A0 (en) Uracil compounds and use thereof
PL357713A1 (en) Caspase inhibitors and uses thereof
HRP20060251B1 (hr) Supstituirani oksazolidinoni i njihova uporaba
PL356066A1 (en) Caspase inhibitors and uses thereof
IL185461A0 (en) Pyrimidine compounds and their use
EP1313477A4 (en) COMPILATIONS AND METHODS
EP1274424A4 (en) CONNECTIONS AND PROCEDURE
GB0101035D0 (en) Formulation and use thereof
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
EG22491A (en) Rest-breaking composition and use thereof
GB0007530D0 (en) Trityl-type compounds and their use
GB0021497D0 (en) Compounds and their use
HUP0303936A3 (en) Novel composition and use
IL152474A0 (en) Antihypertensive agents and use
EP1343796A4 (en) COMPOUNDS AND METHODS
EP1367123A4 (en) NEUROTONIN AND ITS USE
AU5104101A (en) Composition and use
GB9929581D0 (en) Comjpositions and their use
GB9911606D0 (en) Composition and use
GB2357692B (en) Preparation and combination tool
GB0008876D0 (en) IC2CU and IC2IDU
GB0029496D0 (en) Optipouch and optipad